Literature DB >> 33972184

Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis.

Tullika Garg1, Alicia Johns2, Amanda J Young2, Matthew E Nielsen3, Hung-Jui Tan4, Carmit K McMullen5, H Lester Kirchner2, Harvey J Cohen6, Terrence E Murphy7.   

Abstract

INTRODUCTION: Treatment burden is emerging as an important patient-centered outcome for older adults with cancer who concurrently manage geriatric conditions. Our objective was to evaluate the contribution of geriatric conditions to treatment burden in older adults with non-muscle invasive bladder cancer (NMIBC).
METHODS: We identified 73,395 Medicare beneficiaries age 66+ diagnosed with NMIBC (Stage <II) in SEER-Medicare (2001-2014). The primary outcome was treatment burden, defined as health system contact days in the year following NMIBC diagnosis. Explanatory variables were the following geriatric conditions: multimorbidity (≥ 2 chronic conditions), functional dependency, falls, depression, cognitive impairment, weight loss, and urinary incontinence. We used negative binomial regression to model the association between individual geriatric conditions and treatment burden while adjusting for covariates.
RESULTS: At baseline, 64% had multimorbidity and median 3 conditions (IQR 0-5). Prevalence of other geriatric conditions ranged from 5.9%-15.2%. Adjusted mean health system contact was 8.9 days (95% CI 8.6-9.2). Multimorbidity had the largest effect size (adjusted mean 11.8 contact days (95% CI 8.3-8.8)). Each additional chronic condition conferred a 13% increased average number of health system contact (adjusted IRR 1.132, 95% CI 1.129-1.135). Regardless of number of chronic conditions, rural patients consistently had more treatment burden than urban counterparts. DISCUSSION: In this population-based cohort of older NMIBC patients, multimorbidity and rurality were strongly associated with treatment burden in the year following NMIBC diagnosis. These findings highlight the need for interventions that reduce treatment burden due to geriatric conditions among the growing population of older adults with cancer, particularly in rural areas.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Geriatric oncology; Multimorbidity; Patient-centered outcomes; Rural disparities; Treatment burden

Mesh:

Year:  2021        PMID: 33972184      PMCID: PMC8429195          DOI: 10.1016/j.jgo.2021.04.005

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.929


  42 in total

1.  Beyond comorbidity: expanding the definition and measurement of complexity among older adults using administrative claims data.

Authors:  Elizabeth Chrischilles; Kathleen Schneider; June Wilwert; Gregory Lessman; Brian O'Donnell; Brian Gryzlak; Kara Wright; Robert Wallace
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

2.  Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Authors:  Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren
Journal:  Am J Epidemiol       Date:  2011-08-04       Impact factor: 4.897

3.  Understanding patients' experiences of treatment burden in chronic heart failure using normalization process theory.

Authors:  Katie Gallacher; Carl R May; Victor M Montori; Frances S Mair
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

4.  Rationale and design of a randomized controlled trial of home-based primary care versus usual care for high-risk homebound older adults.

Authors:  Jennifer M Reckrey; Abraham A Brody; Elizabeth T McCormick; Linda V DeCherrie; Carolyn W Zhu; Christine S Ritchie; Albert L Siu; Natalia N Egorova; Alex D Federman
Journal:  Contemp Clin Trials       Date:  2018-03-26       Impact factor: 2.226

5.  Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer.

Authors:  Thomas L Jang; Neal Patel; Izak Faiena; Kushan D Radadia; Dirk F Moore; Sammy E Elsamra; Eric A Singer; Mark N Stein; James A Eastham; Peter T Scardino; Yong Lin; Isaac Y Kim; Grace L Lu-Yao
Journal:  Cancer       Date:  2018-09-25       Impact factor: 6.860

Review 6.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

Authors:  Sam S Chang; Stephen A Boorjian; Roger Chou; Peter E Clark; Siamak Daneshmand; Badrinath R Konety; Raj Pruthi; Diane Z Quale; Chad R Ritch; John D Seigne; Eila Curlee Skinner; Norm D Smith; James M McKiernan
Journal:  J Urol       Date:  2016-06-16       Impact factor: 7.450

7.  Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.

Authors:  Eveline A M Heijnsdijk; Daan Nieboer; Tullika Garg; Iris Lansdorp-Vogelaar; Harry J de Koning; Matthew E Nielsen
Journal:  BJU Int       Date:  2018-08-27       Impact factor: 5.588

8.  Development of a patient decision aid for the management of superficial basal cell carcinoma (BCC) in adults with a limited life expectancy.

Authors:  Alexandra Junn; Neha R Shukla; Lily Morrison; Meghan Halley; Mary-Margaret Chren; Louise C Walter; Dominick L Frosch; Dan Matlock; Jeanette S Torres; Eleni Linos
Journal:  BMC Med Inform Decis Mak       Date:  2020-04-29       Impact factor: 2.796

9.  Association of Patient Priorities-Aligned Decision-Making With Patient Outcomes and Ambulatory Health Care Burden Among Older Adults With Multiple Chronic Conditions: A Nonrandomized Clinical Trial.

Authors:  Mary E Tinetti; Aanand D Naik; Lilian Dindo; Darce M Costello; Jessica Esterson; Mary Geda; Jonathan Rosen; Kizzy Hernandez-Bigos; Cynthia Daisy Smith; Gregory M Ouellet; Gina Kang; Yungah Lee; Caroline Blaum
Journal:  JAMA Intern Med       Date:  2019-10-07       Impact factor: 21.873

10.  Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non-Muscle-invasive Bladder Cancer in United States Clinical Practice.

Authors:  Kyle A Richards; Shih-Wen Lin; Ching-Yi Chuo; Christina L Derleth; Jingbo Yi; Marko Zivkovic; Sarika Ogale; Sandip Prasad; G Joel Decastro; Gary D Steinberg
Journal:  Urology       Date:  2020-07-24       Impact factor: 2.649

View more
  1 in total

Review 1.  Rural-Urban Disparities in Cancer Outcomes: Opportunities for Future Research.

Authors:  Smita Bhatia; Wendy Landier; Electra D Paskett; Katherine B Peters; Janette K Merrill; Jonathan Phillips; Raymond U Osarogiagbon
Journal:  J Natl Cancer Inst       Date:  2022-07-11       Impact factor: 11.816

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.